PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Stroke. Author manuscript; available in PMC 2011 July 1.
Published in final edited form as:
PMCID: PMC2945294
NIHMSID: NIHMS232547

Retinal Vascular Caliber and Brachial Flow-Mediated Dilation

The Multi-Ethnic Study of Atherosclerosis

Abstract

Background and Purpose

Retinal vascular caliber changes have been shown to predict stroke, but the underlying mechanism of this association is unknown. We examined the relationship between retinal vascular caliber with brachial flow-mediated dilation (FMD), a measure of systemic endothelial function.

Methods

The Multi-Ethnic Study of Atherosclerosis (MESA) is a population-based study of persons 45 to 84 years of age residing in 6 US communities free of clinical cardiovascular disease at baseline. Brachial FMD data were collected at baseline (July 2000 to June 2002), and retinal vascular caliber was measured from digital retinal photographs at the second examination, immediately after the first (August 2002 to January 2004). Data were available for 2851 participants for analysis.

Results

The mean brachial FMD was 4.39±2.79%. After adjusting for age and gender, brachial FMD was reduced in persons with wider retinal venular caliber (changes in FMD −0.25, 95% CI, −0.36, − 0.13; P<0.001, per SD increase in venular caliber). This relationship persists after adjusting for systolic blood pressure, serum total cholesterol, use of lipid-lowering and antihypertensive medication, body mass index, current smoking status, and hemoglobinA1C (−0.18; 95% CI −0.30, − 0.06; P=0.004, per SD increase in venular caliber). Brachial FMD was not associated with retinal arteriolar caliber.

Conclusions

Persons with wider retinal venules have reduced brachial FMD, independent of other vascular risk factors. This suggests that retinal venular caliber, previously shown to predict stroke, may be a marker of underlying systemic endothelial dysfunction.

Keywords: epidemiology, vasodilation, imaging, endothelial function

Precise measurement of retinal vascular caliber changes are now possible with digital retinal photography and new imaging software.1 Recent population-based studies have shown that changes in retinal vascular caliber, particularly wider venules, may predict stroke and other cardiovascular events.24 For example, wider retinal venules are associated with carotid artery disease,4 MRI-detected lacunar infarcts and white matter lesions,5 and incident clinical stroke,6,7 as well as incident coronary heart disease events and deaths.7

Despite these data, the underlying mechanisms of these associations are unknown. It has been suggested that retinal vascular caliber changes are markers of systemic endothelial dysfunction, but the few studies that have examined this with indirect systemic markers of endothelial function have shown inconsistent results.810

Brachial flow-mediated dilation (FMD) is a validated, noninvasive physiological measure to quantify endothelial function.11 Brachial FMD has been shown previously to be abnormal in persons with type 1 and type 2 diabetes12,13 and in those with diabetic microvascular complications.14 Brachial FMD is linked with various cardiovascular risk factors15 and has been demonstrated to predict future cardiovascular disease events and mortality.16

We hypothesize that retinal vascular caliber may reflect systemic endothelial dysfunction and that this may be a potential mechanism of the associations of retinal vascular caliber and stroke. A previous study in a small population (n=256, with 52 having missing FMD) did not find an association between retinal vascular caliber and brachial FMD.17 In the current study, we assessed this association in a larger, multiethnic, population-based sample.

Methods

Study Population

The Multi-Ethnic Study of Atherosclerosis (MESA) was a prospective cohort study of men and women 45 to 84 years of age comprising 4 racial/ethnic groups (whites, blacks, Hispanics, and Chinese). Participants had no history of clinical cardiovascular disease at baseline and were residents of 6 US communities.18 Tenets of the Declaration of Helsinki were followed, and institutional review board approval was granted at each study site. Written informed consent was obtained from each participant.

There were 6814 participants at the first/baseline examination. FMD data were available from the first examination (July 2000 to June 2002) from 5 of 6 centers. Retinal photography was done in 6176 persons at the second examination (August 2002 to January 2004), which followed the baseline examination by 18 months on average. Exclusion criteria included a systolic blood pressure (BP) >180 mm Hg, a congenital abnormality of the arm or hand, presence of Raynaud’s phenomenon, or a previous history of radical mastectomy. In total, 6089 of the 6814 MESA participants had brachial FMD. However, the original reading protocol did not yield sufficiently accurate measurements, and the scans in a random subset of 3027 participants were reread. Of these, 2851 participants had gradable retinal photographs and were included in this analysis. Table 1 compares included and excluded participants. Included participants had a lower proportion of hypertension, and a higher proportion were male and had lower systolic BP and body mass index (BMI; Table 1).

Table 1
Characteristics of the MESA Study Population (n=2851)

Brachial FMD Measurement

Participants underwent brachial FMD examination after 15 minutes of rest in the fasting state. With the participant supine and using an automated sphygmomanometer, BP at baseline was measured in the left arm, before inflation of the right arm cuff, immediately before release of the occluding cuff, at 1 minute and then at 3 minutes after release of the occluding cuff. BP was measured in both arms to confirm no significant gradients (ie, ≤15 mm Hg). This was to ensure that the maneuver did not cause a change in BP that might have affected the resting tone (diameter) of the artery.

The right brachial artery was imaged with high-resolution ultrasound at the elbow, 3 to 7 cm above the antecubital fossa, where it formed a straight segment, free of major branches. The occlusion BP cuff was placed around the upper right forearm, just below the antecubital fossa. After obtaining baseline images of the right brachial artery (acquired at the fastest frame rate ≥32 Hz) over a 30-second period, the cuff was inflated for 5 minutes (pressure was 200 mm Hg or BP+50 mm Hg if BP was >150 mm Hg). Images of the right brachial artery were captured continuously for 120 seconds after cuff deflation. Videotapes of the acquired images of the brachial artery were analyzed at the Wake Forest University cardiology image processing laboratory using a previously validated semiautomated system (by D.H.).19 The readings of these digitized images generated the baseline and maximum diameters of the brachial artery from which the absolute change from baseline diameter and percentage (%) brachial FMD was computed. FMD was computed with the formula: maximum diameter−baseline diameter×100%/baseline diameter.

Intrareader reproducibility for baseline diameter, maximum diameter, and %FMD was evaluated by comparing an original and a blinded quality control reread of ultrasounds from 40 MESA participants (32 male, 18 white, 2 Chinese, 10 black, and 10 Hispanic subjects). The intraclass correlation coefficients were 0.99, 0.99, and 0.93, respectively. Intrasubject variability was evaluated by comparing results from repeated examinations of 19 subjects on 2 days a week apart. The intraclass correlation coefficients for baseline diameter, maximum diameter, and %FMD were 0.90, 0.90, and 0.54, respectively. Percent technical error of measurement was 1.39% for baseline diameter measurement, 1.47% for maximum diameter measurement, and 28.4% for %FMD measurement.16

Measurement of Retinal Vascular Caliber

Retinal photography was performed using a standardized protocol.20,21 Both eyes of each participant were photographed using a 45-degree 6.3 megapixel digital nonmydriatic camera. Two photographic fields (optic disc and macula) were taken of each eye. Images were sent from the 6 field centers to the Ocular Epidemiology Reading Center at the University of Wisconsin, Madison, for measurement of retinal vascular caliber.

Retinal vascular caliber was measured using a computer-based program by trained graders who were masked to participant characteristics, based on a detailed protocol.20,21 Photographs in the right eye were selected for measurement; the left eye was chosen if measurements could not be performed in the right eye. For each image, all arterioles and venules coursing through an area one-half to one-disc diameter from the optic disc margin were measured and summarized as the central retinal artery equivalent and central retinal vein equivalent.20,21 These equivalents were projected calibers for the central retinal vessels, measured away from the optic disc. Reproducibility of these measurements had been reported, with intragrader and intergrader intraclass–correlation coefficients ranging from 0.78 to 0.99.20,21

Assessment of Cardiovascular Risk Factors

A detailed questionnaire was used to obtain participant information, including past medical history, alcohol intake, and cigarette smoking.18,22 Diabetes mellitus was defined as fasting glucose ≥7.0 mmol/L (126 mg/dL) or history of diabetes and the use of insulin or oral hypoglycemic medications (13). Hypertension was defined as systolic BP ≥140 mm Hg, diastolic BP ≥90 mm Hg, or current use of antihypertensive medications. Height and weight were measured to determine BMI, defined as kilograms per meter squared (weight/height). Fasting (>8 hours) blood samples were drawn from participants, and aliquots were prepared for central analysis. We used total cholesterol, high-density and low-density lipoprotein cholesterol, high sensitive C-reactive protein, and hemoglobinA1C in this analysis.

Statistical Analysis

Retinal vascular caliber was categorized into quartiles for analysis and also analyzed as a continuous variable (per 1-SD changes in retinal arteriolar and venular caliber). We used ANCOVA to estimate mean FMD for quartiles of arteriolar and venular caliber and linear regression to determine the change in FMD per SD change in arteriolar and venular caliber, adjusting for age, gender, race/ethnicity, and cardiovascular risk factors, including total cholesterol, systolic BP, use of lipid-lowering and antihypertensive medication, BMI, current smoking status, and hemoglobinA1C. We examined potential interaction by age (>65 years and <65 years), gender, race/ethnicity, diabetes, and hypertension. In models for arteriolar caliber, we adjusted for venular caliber (and vice versa) to account for potential confounding from fellow vascular caliber.23 All analyses were performed in SPSS version 16.0.1 (SPSS Inc).

Results

Selected characteristics and risk factors for each of 4 races/ethnicity: whites (n=981), blacks (n=595), Hispanics (n=706), and Chinese (n=569), among participants who have brachial FMD and retinal photographs (n=2851) are shown in Table 1. Whites have lower prevalence of diabetes, higher brachial FMD, and lower baseline brachial artery diameter compared with nonwhites. In addition, those who have FMD performed have a lower proportion of hypertension, and a higher proportion is male, as well as lower systolic BP and BMI (Table 1).

Brachial FMD is reduced in persons with wider retinal venular caliber (Table 2). Brachial FMD is 0.25% lower (95% CI, −0.36, −0.13; P<0.001) per SD increase in venular caliber. This relationship persists after adjusting for serum total cholesterol, systolic BP, use of lipid-lowering and antihypertensive medication, BMI, current smoking, and hemoglobinA1C; brachial FMD is lower by 0.18% (95% CI, −0.30, −0.06; P=0.004) per SD increase in venular caliber. Additional adjustment for time between examinations, diabetes status, alcohol consumption, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol, or C-reactive protein does not change the associations (data not shown). There is no association between arteriolar caliber and brachial FMD after multivariable adjustment.

Table 2
Relationship of Brachial FMD and Baseline Brachial Artery Diameter With Retinal Arteriolar and Venular Caliber

Table 2 also shows an association between wider venular caliber and baseline brachial artery diameter (0.049 mm; 95% CI, 0.020 to 0.077; P=0.001; increase in baseline brachial artery diameter per SD increase in venular caliber) and between narrower arteriolar caliber and baseline brachial artery diameter (0.031 mm; 95% CI, 0.002 to 0.059; P=0.03; increase in brachial artery diameter per SD decrease in arteriolar caliber). The significant associations disappear after adjustment for baseline brachial diameter (data not shown).

Table 3 shows stratified analysis of the association of retinal venular caliber with brachial FMD, stratified by diabetes and hypertension status, and ethnicity/race, adjusting for serum total cholesterol, systolic BP, use of lipid-lowering and antihypertensive medication, BMI, current smoking status and hemoglobinA1C. Brachial FMD is generally lower in persons with wider venular caliber quartile (fourth quartile compared with other 3 quartiles), in those with and without diabetes or hypertension and in the 4 ethnic/racial groups. Interaction terms for diabetes, hypertension, and ethnicity/race are not significant (data not shown). The associations between brachial FMD or baseline brachial diameter and retinal arteriolar caliber are no longer statistically significant, except between arteriolar caliber and brachial FMD in those with hypertension (3.83% ±3.48 versus 4.16% ±4.25; P=0.04; comparing narrowest first quartile versus second with fourth quartiles; data not shown).

Table 3
Relationship of Brachial FMD With Retinal Venular Caliber, Stratified by Diabetes and Hypertension Status and Race/Ethnicity

Discussion

In this population-based study of persons free of clinical cardiovascular disease, we show that wider retinal venular caliber is associated with reduced brachial FMD, independent of traditional cardiovascular risk factors. Our study suggests that retinal venular caliber may reflect underlying systemic endothelial dysfunction, and that this may provide a novel explanation of why retinal venular caliber predicts incident stroke and other cardiovascular events.

To our best knowledge, there has only been one published study with which to compare our findings. An analysis from the Hoorn study of 256 persons 60 to 85 years of age (of 631 eligible, with 6 missing retinal photographs and 52 missing FMD) showed that after controlling for age, sex, glucose tolerance, baseline diameter, and increase in peak systolic velocity, wider venules were associated with reduced brachial FMD,17 although this was not statistically significant.

Our study findings may provide additional insights into previously demonstrated associations between retinal venular caliber and a range of cardiovascular risk factors and diseases. Wider venules have been shown to associate with carotid artery disease,4 MRI-detected lacunar infarcts and white matter lesions,5 and incident clinical stroke,3,6,7 as well as incident coronary heart disease events and deaths.7 Further, wider retinal venules have been linked with the metabolic syndrome,24 serum markers of inflammation,25 and other markers of atherosclerosis, such as lower ankle–arm index, higher carotid plaque score, and increased aortic calcification,26 as well as reduced small–artery compliance,27 which have been suggested to also reflect endothelial dysfunction.28 Our study suggests that variation in retinal venules may reflect underlying systemic endothelial dysfunction.

In addition, we also found association of larger baseline brachial artery diameter with wider retinal venules. Larger baseline brachial artery diameter has been found to be predictive of cardiovascular events in the Cardiovascular Health Study, and its predictive value is similar to that of brachial FMD.29 In addition, larger baseline brachial artery is associated with narrower retinal arterioles in our study. Narrower retinal arterioles are associated with risk of type 2 diabetes,30 hypertension,3134 incident coronary heart disease events, and deaths. Additional research is needed to clarify the significance of these relationships with brachial artery diameter.

The strengths of this study include a large population-based sample and the use of quantitative measures of retinal vascular caliber and FMD. Limitations of this study should also be noted. First, the cross-sectional nature of the study limits our ability to judge temporal sequence of associations. Second, FMD and retinal photography were not done at the same visit. This is important because brachial FMD and retinal vascular caliber may fluctuate and be influenced by physiological factors. Further, this could have distorted the associations between FMD and retinal vessel measurements, and this may explain why no relationship was found between FMD and arteriolar caliber. Adherence to guidelines for measuring brachial artery reactivity minimizes but does not eliminate the variability of brachial FMD. Third, there were a proportion of MESA participants with no FMD data, and this may bias our results because those who had FMD performed have a lower proportion of hypertension, there was a higher proportion of males, and lower systolic BP and BMI. Fourth, in our analysis, there was a much greater difference of FMD between retinal venular categories in whites than for other racial/ethnic groups. Therefore, we are uncertain whether the association between wider retinal venules and reduced FMD would be apparent with a larger sample of the nonwhite ethnic groups. In addition, the significant relationships disappear after additional adjustment of baseline brachial FMD. From our analysis, we are unable to determine whether this is attributable to statistical overadjustment because the percentage of brachial FMD is also computed from brachial diameter or changes in brachial diameter being an inverse predictor of FMD.35 Finally, it was not possible to perform endothelium-independent vasodilation with nitroglycerin in a population-based study, so although brachial FMD is associated with retinal vascular caliber, we cannot be certain that the relationship is entirely attributable to endothelium-dependent vasodilation.

Summary

In conclusion, in this large population-based study, wider retinal venular caliber is associated with reduced brachial FMD, independent of traditional cardiovascular risk factors. Our study provides the first line of evidence to suggest that retinal venular caliber may reflect systemic endothelial function, and that this may explain the relationship between changes in retinal venular caliber and incident stroke and other cardiovascular disease. If supported by additional research, quantitatively measured retinal vascular caliber may be a novel, noninvasive measure of systemic endothelial function.

Acknowledgments

We thank the other investigators, staff, and participants of the MESA study for their valuable contributions.

Sources of Funding

This research was supported by N01-HC-95159 through N01-HC-95165 and N01-HC-95169 from the National Heart, Lung, and Blood Institute. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. Additional support was provided by NIH grant HL69979-03 (R.K., T.Y.W.) and Z01EY00403 (M.F.C.).

Footnotes

Disclosures

None.

References

1. Nguyen TT, Wang JJ, Wong TY. Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications. Diabetes Care. 2007;30:2708–2715. [PubMed]
2. Baker ML, Hand PJ, Wang JJ, Wong TY. Retinal signs and stroke: revisiting the link between the eye and brain. Stroke. 2008;39:1371–1379. [PubMed]
3. McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE, Wang JJ, Mitchell P, Vingerling JR, de Jong PT, Witteman JC, Breteler MM, Shaw J, Zimmet P, Wong TY. Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol. 2009;170:1323–1332. [PMC free article] [PubMed]
4. De Silva DA, Liew G, Wong MC, Chang HM, Chen C, Wang JJ, Baker ML, Hand PJ, Rochtchina E, Liu EY, Mitchell P, Lindley RI, Wong TY. Retinal vascular caliber and extracranial carotid disease in patients with acute ischemic stroke: the Multi-Centre Retinal Stroke (MCRS) study. Stroke. 2009;40:3695–3699. [PubMed]
5. Lindley RI, Wang JJ, Wong MC, Mitchell P, Liew G, Hand P, Wardlaw J, De Silva DA, Baker M, Rochtchina E, Chen C, Hankey GJ, Chang HM, Fung VS, Gomes L, Wong TY. Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol. 2009;8:628–634. [PubMed]
6. Ikram MK, de Jong FJ, Bos MJ, Vingerling JR, Hofman A, Koudstaal PJ, de Jong PT, Breteler MM. Retinal vessel diameters and risk of stroke: the Rotterdam Study. Neurology. 2006;66:1339–1343. [PubMed]
7. Wong TY, Kamineni A, Klein R, Sharrett AR, Klein BE, Siscovick DS, Cushman M, Duncan BB. Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the Cardiovascular Health Study. Arch Intern Med. 2006;166:2388–2394. [PubMed]
8. Klein R, Klein BE, Knudtson MD, Wong TY, Tsai MY. Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study. Arch Ophthalmol. 2006;124:87–94. [PubMed]
9. Klein R, Sharrett AR, Klein BE, Chambless LE, Cooper LS, Hubbard LD, Evans G. Are retinal arteriolar abnormalities related to atherosclerosis? The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol. 2000;20:1644–1650. [PubMed]
10. Wong TY, Islam FM, Klein R, Klein BE, Cotch MF, Castro C, Sharrett AR, Shahar E. Retinal vascular caliber, cardiovascular risk factors, and inflammation: the Multi-Ethnic Study of Atherosclerosis (MESA) Invest Ophthalmol Vis Sci. 2006;47:2341–2350. [PMC free article] [PubMed]
11. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111–1115. [PubMed]
12. Pinkney JH, Downs L, Hopton M, Mackness MI, Bolton CH. Endothelial dysfunction in type 1 diabetes mellitus: relationship with LDL oxidation and the effects of vitamin E. Diabet Med. 1999;16:993–999. [PubMed]
13. Meeking DR, Cummings MH, Thorne S, Donald A, Clarkson P, Crook JR, Watts GF, Shaw KM. Endothelial dysfunction in type 2 diabetic subjects with and without microalbuminuria. Diabet Med. 1999;16:841–847. [PubMed]
14. Jin SM, Noh CI, Yang SW, Bae EJ, Shin CH, Chung HR, Kim YY, Yun YS. Endothelial dysfunction and microvascular complications in type 1 diabetes mellitus. J Korean Med Sci. 2008;23:77–82. [PMC free article] [PubMed]
15. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468–1474. [PubMed]
16. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the Multi-Ethnic Study of Atherosclerosis. Circulation. 2009;120:502–509. [PMC free article] [PubMed]
17. van Hecke MV, Dekker JM, Nijpels G, Stolk RP, Henry RMA, Heine RJ, Bouter LM, Stehouwer CD, Polak BC. Are retinal microvascular abnormalities associated with large artery endothelial dysfunction and intima-media thickness? The Hoorn Study. Clin Sci (Lond) 2006;110:597–604. [PubMed]
18. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR, Jr, Kronmal R, Liu K, Nelson JC, O’Leary D, Saad MF, Shea S, Szklo M, Tracy RP. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871–881. [PubMed]
19. Loehr LR, Espeland MA, Sutton-Tyrrell K, Burke GL, Crouse JR, III, Herrington DM. Racial differences in endothelial function in postmenopausal women. Am Heart J. 2004;148:606–611. [PubMed]
20. Wong TY, Knudtson MD, Klein R, Klein BE, Meuer SM, Hubbard LD. Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology. 2004;111:1183–1190. [PubMed]
21. Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS, Sharrett AR, Davis MD, Cai J. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology. 1999;106:2269–2280. [PubMed]
22. MESA Coordinating Center. University of Washington. Multi-Ethnic Study of Atherosclerosis Field Center Manual of Operations. Jan 5, 2001.
23. Liew G, Sharrett AR, Kronmal R, Klein R, Wong TY, Mitchell P, Kifley A, Wang JJ. Measurement of retinal vascular caliber: issues and alternatives to using the arteriole to venule ratio. Invest Ophthalmol Vis Sci. 2007;48:52–57. [PubMed]
24. Kawasaki R, Tielsch JM, Wang JJ, Wong TY, Mitchell P, Tano Y, Tominaga M, Oizumi T, Daimon M, Kato T, Kawata S, Kayama T, Yamashita H. The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata Study. Br J Ophthalmol. 2008;92:161–166. [PubMed]
25. Nguyen TT, Wong TY. Retinal vascular manifestations of metabolic disorders. Trends Endocrinol Metab. 2006;17:262–268. [PubMed]
26. Ikram MK, de Jong FJ, Vingerling JR, Witteman JC, Hofman A, Breteler MM, de Jong PT. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci. 2004;45:2129–2134. [PubMed]
27. Cheung N, Islam FM, Jacobs DR, Jr, Sharrett AR, Klein R, Polak JF, Cotch MF, Klein BE, Ouyang P, Wong TY. Arterial compliance and retinal vascular caliber in cerebrovascular disease. Ann Neurol. 2007;62:618–624. [PubMed]
28. McVeigh GE, Allen PB, Morgan DR, Hanratty CG, Silke B. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis. Clin Sci (Lond) 2001;100:387–393. [PubMed]
29. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 2007;115:2390–2397. [PubMed]
30. Nguyen TT, Wang JJ, Islam FM, Mitchell P, Tapp RJ, Zimmet PZ, Simpson R, Shaw J, Wong TY. Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetes. 2008;57:536–539. [PubMed]
31. Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Klein BE, Hubbard LD, Nieto FJ. Retinal arteriolar diameter and risk for hypertension. Ann Intern Med. 2004;140:248–255. [PubMed]
32. Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD. Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ. 2004;329:79. [PMC free article] [PubMed]
33. Smith W, Wang JJ, Wong TY, Rochtchina E, Klein R, Leeder SR, Mitchell P. Retinal arteriolar narrowing is associated with 5-year incident severe hypertension: the Blue Mountains Eye Study. Hypertension. 2004;44:442–447. [PubMed]
34. Ikram MK, Witteman JC, Vingerling JR, Breteler MM, Hofman A, de Jong PT. Retinal vessel diameters and risk of hypertension: the Rotterdam Study. Hypertension. 2006;47:189–194. [PubMed]
35. Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol. 2005;568:357–369. [PubMed]